Taken together, the results presented here provide a comprehensive view of the landscape of genomic alterations including CNAs, LOH, CNN-AI and tumor DNA ploidy occurring in HER2-amplified tumors in context of other BC subgroups. Here, ERBB2 is linked to breast cancer.